Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News NVN Liquidation Inc NOVNQ

Healthcare
NVN Liquidation, Inc., formerly Novan, Inc., has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:NOVNQ)

Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection

GlobeNewswire July 17, 2023

Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders

GlobeNewswire June 5, 2023

Novan Focuses Strategic Direction and Announces Restructuring

GlobeNewswire May 31, 2023

Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire May 15, 2023

Novan to Report First Quarter 2023 Financial Results on May 15, 2023

GlobeNewswire May 8, 2023

Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹

GlobeNewswire April 27, 2023

Novan to Host Analyst and Investor Event: A Discussion of Molluscum's Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD

GlobeNewswire April 20, 2023

Novan Reports Full Year 2022 Financial Results and Provides Corporate Update

GlobeNewswire March 30, 2023

Novan to Report Full Year 2022 Financial Results on March 30, 2023

GlobeNewswire March 23, 2023
View More News ››

Opinion & Analysis (OTCPK:NOVNQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:NOVNQ)

This is Going to Change Society

Kevin Harrington: "I believe a product like this has been needed for decades because too many people are dying of alcohol-related...
Peng26 - April 13, 2023

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
Melany4 - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

   
Melany4 - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
Melany4 - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

 
Melany4 - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

Melany4 - May 11, 2022
View more Bullboard ››

BioVaxys Technology Corp.

BioVaxys Technology Corp.

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving ...
View More »